What are the implications of methyldopa use in patients with Parkinson’s disease and how does its interaction with dopaminergic pathways influence treatment outcomes?
Lakshya KumarExplorer
What are the implications of methyldopa use in patients with Parkinson’s disease?
Share
Methyldopa may exacerbate Parkinson’s symptoms by interfering with dopamine synthesis, potentially worsening motor control and requiring adjustments in dopaminergic treatments.